Trends & Perspectives

Changing the Face of Cancer Research

Christopher Ung, Vice President, Strategic Business & Operations, Oncology, at TMD, a Quintiles Central Laboratory, explains how advances in biomarker technology are ushering in a new era of cancer therapy development.

Find out more

Presentation

Tissue Biomarkers in Oncology Clinical Development: The Digital Advantage

The advantages of incorporating digital pathology into your oncology clinical development process.

View now

Send Us Your RFP

Submit request

Tell Us What You Think

Rate your Quintiles.com experience

Learn more about Oncology

Oncology

Complete Oncology Trial & Commercialization Services

Complex. Specialized. Targeted. These attributes describe your work fighting cancer. Quintiles' highly trained, specialized oncology clinical trial professionals, including MDs, medical writers, regulatory and late phase staff are experts at studying complexities and recommending targeted solutions.

And our relationships within the oncology community give us access to key opinion leaders and patients at leading cancer centers worldwide. We have enrolled more than 35,000 patients in oncology trials since 2004.

Increasing Focus on Targeted Therapies

Not only does our expertise cover drug classes like cytostatics, cytotoxics, hormonal therapies, cytokines, hematopoietic growth factors as well as supportive care but we have a wealth of experience with newer anti-cancer drugs like: 

  • Monoclonal antibodies
  • Small molecule tyrosine kinase inhibitors 
  • Anti-angiogenics 
  • Many other targeted therapies 
  • Anti-cancer vaccines 
  • Gene therapy 
  • New delivery systems

Specialty Care Sales Teams Deliver Revenues

After the euphoria settles from receiving regulatory approval, the business of marketing and selling moves into high gear. We can build a communication plan and develop a single or multi-country sales team. Read more about pharmaceutical commercial services.